Cazzola M - Search Results

1

Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.

Molteni E, Bono E, Gallì A, Elena C, Ferrari J, Fiorelli N, Pozzi S, Ferretti VV, Sarchi M, Rizzo E, Camilotto V, Boveri E, Cazzola M, Malcovati L. Molteni E, et al. Among authors: cazzola m. Blood. 2023 Aug 17;142(7):643-657. doi: 10.1182/blood.2022019304. Blood. 2023. PMID: 37216690 Free PMC article.

2

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.

Cazzola M, Ponchio L, Beguin Y, Rosti V, Bergamaschi G, Liberato NL, Fregoni V, Nalli G, Barosi G, Ascari E. Cazzola M, et al. Blood. 1992 Jan 1;79(1):29-37. Blood. 1992. PMID: 1728318 Free article. Clinical Trial.

3

Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.

Cazzola M, Ponchio L, de Benedetti F, Ravelli A, Rosti V, Beguin Y, Invernizzi R, Barosi G, Martini A. Cazzola M, et al. Blood. 1996 Jun 1;87(11):4824-30. Blood. 1996. PMID: 8639855 Free article.

4

Hematologic passport for athletes competing in endurance sports: a feasibility study.

Malcovati L, Pascutto C, Cazzola M. Malcovati L, et al. Among authors: cazzola m. Haematologica. 2003 May;88(5):570-81. Haematologica. 2003. PMID: 12745277

5

Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.

Passamonti F, Vanelli L, Malabarba L, Rumi E, Pungolino E, Malcovati L, Pascutto C, Morra E, Lazzarino M, Cazzola M. Passamonti F, et al. Among authors: cazzola m. Haematologica. 2003 Oct;88(10):1123-9. Haematologica. 2003. PMID: 14555308

6

Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders.

Passamonti F, Pietra D, Malabarba L, Rumi E, Della Porta MG, Malcovati L, Bonfichi M, Pascutto C, Lazzarino M, Cazzola M. Passamonti F, et al. Among authors: cazzola m. Br J Haematol. 2004 Sep;126(5):650-6. doi: 10.1111/j.1365-2141.2004.05098.x. Br J Haematol. 2004. PMID: 15327515 Free article.

7

Ferroportin gene silencing induces iron retention and enhances ferritin synthesis in human macrophages.

Gallí A, Bergamaschi G, Recalde H, Biasiotto G, Santambrogio P, Boggi S, Levi S, Arosio P, Cazzola M. Gallí A, et al. Among authors: cazzola m. Br J Haematol. 2004 Dec;127(5):598-603. doi: 10.1111/j.1365-2141.2004.05238.x. Br J Haematol. 2004. PMID: 15566364 Free article.

8

Myelodysplastic syndromes--coping with ineffective hematopoiesis.

Cazzola M, Malcovati L. Cazzola M, et al. N Engl J Med. 2005 Feb 10;352(6):536-8. doi: 10.1056/NEJMp048266. N Engl J Med. 2005. PMID: 15703418 No abstract available.

9

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.

Malcovati L, Della Porta MG, Lunghi M, Pascutto C, Vanelli L, Travaglino E, Maffioli M, Bernasconi P, Lazzarino M, Invernizzi R, Cazzola M. Malcovati L, et al. Among authors: cazzola m. Leukemia. 2005 May;19(5):776-83. doi: 10.1038/sj.leu.2403680. Leukemia. 2005. PMID: 15789068 Clinical Trial.

10

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

Malcovati L, Porta MG, Pascutto C, Invernizzi R, Boni M, Travaglino E, Passamonti F, Arcaini L, Maffioli M, Bernasconi P, Lazzarino M, Cazzola M. Malcovati L, et al. Among authors: cazzola m. J Clin Oncol. 2005 Oct 20;23(30):7594-603. doi: 10.1200/JCO.2005.01.7038. Epub 2005 Sep 26. J Clin Oncol. 2005. PMID: 16186598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,243 results

Search Page

Filters